Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,634
Out of 4,784 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $1.98 | -39.39% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $1.30 | +36,823.08% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $750,000 | $1.30 | +57,692,207.69% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $8.20 | +27,339.02% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $40.33 | +420.70% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $1.98
Upside: -39.39%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.30
Upside: +36,823.08%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $750,000
Current: $1.30
Upside: +57,692,207.69%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $8.20
Upside: +27,339.02%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $40.33
Upside: +420.70%